Drug manufacturers must advise health care providers about risks a drug may present to a patient’s close contacts, a Staten Island Supreme Court justice has ruled in a case of first impression for New York state courts.

Justice William F. Mastro adopted a recent recommendation contained in the Restatement (Third) of Torts in a case where the father of a child being vaccinated against polio contracted paralytic poliomyelitis.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]